SlideShare ist ein Scribd-Unternehmen logo
1 von 66
Calculations of risk scores 
Possum e 
derivati,EPASS,VBHOM,surgical 
apgar,Saps,Apache,Sofa….
• SAPS?? 
• APACHE??
Risk prediction on line 
• Risk prediction in surgery 
[http://www.riskprediction.org.uk/p 
pindex.php]. 
• SFAR
• This site has been developed to allow surgeons to estimate risk online for 
their patients undergoing surgery. This service is provided for individual 
use to help surgeons more fully consent their patients by giving mortality 
and other surgical risk predictions based on relevant prognostic factors 
including age, disease severity and co-morbidity. Risk adjusted operative 
mortality can be used as an objective measure of outcome for monitoring 
performance within a centre or between centres.
Surgical Risk scores 
• ACPGBI CRC Model - Association of Coloproctology of GB & I Colorectal Cancer Model for 
mortality in colorectal cancer 
• ACPGBI MBO Model - Association of Coloproctology of GB & I model for mortality 
prediction in malignant bowel obstruction 
• ACPGBI Lymph Node Harvesting Model - Association of Coloproctology of GB & I model for 
determining the number of nodes that should be found in each resection 
• St Mark's Lymph Node Positivity Model - calculates the probability of lymph node 
metastases in patients undergoing local resection of rectal cancers and for patients whose 
nodal harvest was not sufficient to adequately stage the rectal cancer. 
• CCF CLC Model - The Cleveland Clinic Colorectal Laparoscopic Conversion Model for 
prediction of conversion of lapararoscopic to open surgery in patients undergoing colonic 
or rectal surgery for benign or malignant disease. 
• CCF IPF Model - The Cleveland Clinic Ileal Pouch Failure Model for prediction of ileal pouch 
failure in patients undergoing restorative proctocolectomy. 
• CR-POSSUM - Used for predicting mortality in Colorectal Surgery (benign & malignant) 
• P-POSSUM - Used for predicting mortality (& morbidity by POSSUM) in General Surgery 
• O-POSSUM - Used for predicting mortality in Oesophagogastric Surgery 
• Vascular-POSSUM - Used for predicting mortality in Vascular Surgery (all 4 models 
available 
• MUST screening tool (malnutrition)
calculate a mortality risk online for patients using the 
ACPGBI Colorectal Cancer Model 
• Calculate an ACP Score 
• Choose a value in each category that matches your patient from the drop down 
lists in both the physiological and operative parameters tables below. Default 
values (the lowest score) are shown for each category. Simply submitting the form 
as it is without changing the values (i.e. a young fit patient having a minor 
operation) still gives a % risk for mortality. It is important to say in this model by 
ticking the appropriate box whether or not the cancer was resected. The reason 
for this is the value allocated to ASA status is dependent upon resection status. 
• Parameters 
– Age 
– Cancer Resection Status cancer resected cancer NOT resected 
– ASA Status C 
– Cancer Staging :Duke’s 
– Operative Urgency ;elective,urgent,emergency
• POSSUM: 
• physiological and operative 
severity scoring system for 
enumeration of morbidity and 
mortality
Calculate a CR-POSSUM Score 
• Choose a value in each category that matches 
your patient from the drop down lists in both 
the physiological and operative parameters 
tables below. Default values (the lowest score) 
are shown for each category. Simply submitting 
the form as it is without changing the values 
(i.e. a young fit patient having a minor 
operation) still gives a v.small % risk for 
mortality. The more 'risky' the procedure the 
more accurate is the predicted risk calculated 
below.
CR POSSUM 
• Physiological Parameters 
– Age 
– Cardiac :No-mild/moderate Carcdiac failure/severe CF 
– Systolic BP 
– Pulse Rate 
– Haemoglobin 
– Urea 
• If calculating risk in a preoperative patient you will need to estimate the 
parameters below. You can return and modify the parameters post-operatively 
if required. 
– Operative Parameters 
– Operation Type 
• Peritoneal Contamination 
• Malignancy Status 
• CEPOD
Calculate a P-POSSUM Score 
Choose a value in each category that matches your patient from the drop 
down lists in both the physiological and operative parameters tables 
below. Default values (the lowest score) are shown for each category. 
Simply submitting the form as it is without changing the values (i.e. a 
young fit patient having a minor operation) still gives a % risk for 
morbidity and mortality. This illustrates that even in the modified P-POSSUM 
formula used in this application still overestimates risk in low risk 
groups. The more 'risky' the procedure the more accurate is the predicted 
risk calculated below.
P-POSSUM score 
Physiological Parameters 
Age 
Cardiac 
Respiratory 
ECG 
Systolic BP 
Pulse Rate 
Haemoglobin 
WBC 
Urea 
Sodium 
Potassium 
GCS I 
f calculating risk in a preoperative patient you will need to estimate the 
parameters below. You can return and modify the parameters post-operatively 
if required. 
Operative Parameters :Operation Type /Number of procedures/ Operative 
Blood Loss/ Peritoneal Contamination/ Malignancy Status/ CEPOD
Calculate an O-POSSUM Score 
• Choose a value in each category that matches your patient from the drop 
down lists in both the physiological and operative parameters tables 
below. You must enter the patients actual age as well as selecting the 
age range otherwise an error will occur. Default values (the lowest score) 
are shown for each category. Simply submitting the form as it is without 
changing the values (i.e. a young fit patient having a minor operation) still 
gives a % risk for mortality.
O Possum score 
• Physiological Parameters 
– Age Range 
– * BOTH FIELDS MUST BE COMPLETED 
– Actual Age * BOTH FIELDS MUST BE COMPLETED 
– Cardiac 
– Respiratory 
– ECG 
– Systolic BP 
– Pulse Rate 
– Haemoglobin 
– WBC 
– Urea 
– Sodium 
– Potassium 
– GCS 
– If calculating risk in a preoperative patient you will need to estimate the parameters below. 
You can return and modify the parameters post-operatively if required. 
• Operative Parameters :Operation Type/ Malignancy Status/ CEPOD
Equazione di Possum(da Copeland) 
• R1 rischio di mortalità 
• R2:rischio di morbilità 
• Una volta ottenuti i punteggi: 
• - Ln (R1/1 - R1) = -7,04 + (0,13 x punteggio fisiologico) + (0,16 x 
punteggio di gravità operatoria). 
• - Ln (R2/1 - R2) = -5,91 + (0,16 x punteggio fisiologico) + (0,19 x 
punteggio di gravità operatoria).
Equazioni di POSSUM 
• R1:Rischio di mortalità 
• R2:Rischio di morbilità: 
• Una volta ottenuti i punteggi: 
• R1=- Ln (R1/1 - R1) = -7,04 + (0,13 x punteggio 
fisiologico) + (0,16 x punteggio di gravità op). 
• R2=- Ln (R2/1 - R2) = -5,91 + (0,16 x punteggio 
fisiológico) + (0,19 x punteggio di gravità op)
World J Surg Oncol. 2008 Apr 9;6:39. Application of Portsmouth 
modification of physiological and operative severity scoring system 
for enumeration of morbidity and mortality (P-POSSUM) in 
pancreatic surgery. Tamijmarane A, Bhati CS, Mirza DF, Bramhall SR, 
Mayer DA, Wigmore SJ, Buckels JA. 
• BACKGROUND: Pancreatoduodenectomy (PD) is associated with high incidence of 
morbidity and mortality. We have applied P-POSSUM in predicting the incidence of 
outcome after PD to identify those who are at the highest risk of developing 
complications. METHOD: A prospective database of 241 consecutive patients who had 
PD from January 2002 to September 2005 was retrospectively updated and analysed. P-POSSUM 
score was calculated for each patient and correlated with observed morbidity 
and mortality. RESULTS: 30 days mortality was 7.8% and morbidity was 44.8%. Mean 
physiological score was 16.07 +/- 3.30. Mean operative score was 13.67 +/- 3.42. Mean 
operative score rose to 20.28 +/- 2.52 for the complex major operation (p < 0.001) with 
2 fold increase in morbidity and 3.5 fold increase in mortality. For groups of patients 
with a physiological score of (less than or equal to) 18, the O:P (observed to Predicted) 
morbidity ratio was 1.3-1.4 and, with a physiological score of >18, the O:P ratio was 
nearer to 1. Physiological score and white cell count were significant in a multivariate 
model. CONCLUSION: P-POSSUM underestimated the mortality rate. While P-POSSUM 
analysis gave a truer prediction of morbidity, underestimation of morbidity and 
potential for systematic inaccuracy in prediction of complications at lower risk levels is a 
significant issue for pancreatic surgery
Stratification of morbidity according to physiology score Horizontal lines 
within boxes, boxes and error bars represent median, interquartile range and 
range respectively. P < 0.001 (Kruskal Wallis Test).
Ding LA, Sun LQ, Chen SX, Qu LL, Xie DF. Modified 
physiological and operative score for the enumeration of 
mortality and morbidity risk assessment model in general 
surgery. World J Gastroenterol 2007; 13(38): 5090-5095 
• AIM: To establish a scoring system for predicting the incidence of postoperative complications and 
mortality in general surgery based on the physiological and operative severity score for the enumeration 
of mortality and morbidity (POSSUM), and to evaluate its effi cacy. 
• METHODS: Eighty-four patients with postoperative complications or death and 172 patients without 
postoperative complications, who underwent surgery in our department during the previous 2 years, 
were retrospectively analyzed by logistic regression. Fifteen indexes were investigated including age, 
cardiovascular function, respiratory function, blood test results, endocrine function, central nervous 
system function, hepatic function, renal function, nutritional status, extent of operative trauma, and 
course of anesthesia. Modifi ed POSSUM (M-POSSUM) was developed using significant risk factors with 
its effi cacy evaluated. 
• RESULTS: The significant risk factors were found to be age, cardiovascular function, respiratory 
function, hepatic function, renal function, blood test results, endocrine function, nutritional status, 
duration of operation, intraoperative blood loss, and course of anesthesia. These factors were all 
included in the scoring system. There were signifi cant differences in the scores between the patients 
with and without postoperative complications, between the patients died and survived with 
complications, and between the patients died and survived without complications. The receiver 
operating characteristic curves showed that the M-POSSUM could accurately predict postoperative 
complications and mortality. 
• CONCLUSION: M-POSSUM correlates well with postoperative complications and mortality, and is more 
accurate than POSSUM
physiological and operative severity 
score for the enumeration of mortality and morbidity 
(POSSUM) 
• POSSUM is limited by its somewhat subjective 
nature and incomplete evaluation of cardiac 
signs. We propose the modified POSSUM (M-POSSUM) 
as a reasonable, practical and 
objective scoring system that can be used 
across a broad disease spectrum in general 
surgery
M-POSSUM indice 0 1 2 3 4 
età <60 60-69 70-79 >80 
Sist circolatorio Normale:funz.cardiaca,PA,ECG Funz cardiaca grado 1:lieve 
ipertens e anormalità 
ECG,bradicardia o 
tachic,sinoatriale,basso 
voltaggio derivaz arti inf,BBB 
Funz cardiaca grado 2:moderata 
ipertens controllata da 
terapia,extrasistoli atriale 
occasionali 
Funz.cardiaca grado 3:IM<3 
mesi,ipertens moderata in 
terapia,ritmi ectopici,modificaz 
ST-T,fibrillaz.atriale. 
Insufficienza cardiaca 
seria,ins.cardiaca 
acuta,malattia ipertensiva 
Sist.respiratorio normale Fumo di vecchia 
data,bronchite 
cronica,asma,infezioni 
respiratorie,strie polmonari 
,ispessimenti 
Modesta COPD,modesta 
alteraz.funz.resp,modesto 
enfisema 
Moderata COPD,funz resp da 
moderata a seriamente 
anormale 
Insufficienza respiratoria 
Funz.epatica normale Storia di 
epatite/cirrosi,bilirub 
tot.<34,2 mmol/l 
bilirub tot.34,2-51.3 
mmol/l 
bilirub tot.>51.3 mmol/l 
Funz.renale normale BUN<10.1 
mmol/lt,Creatinin.<170 
mmol/l 
BUN 10.1-15 mmol/lt,creat 
170-300 mmol/l 
Insuff renale in dialisi 
Tratto gastrointestinale normale Storia di gastroenterite 
cronica,ulcera peptica 
ben controllata 
Malattia gastrointest 
attiva/emorragia/perforaz 
di ulcera,m.di Crohn. attiva 
Fistola intest.percutanea Sindr.intestino 
corto,trapianto di 
intestino 
ematopoietico normale Piastrine /GB 
lievemente diminuiti,HB 
>85 gr/l 
Malattia,come leucemia 
,stabile;GB>14.5 *109/l 
Mal.aplastica,sindr da 
ipersplenismo,leucemia,e 
cc. 
endocrino normale Glicemia lievemente 
aumentata,glucosio urinario 
assente,ipertiroidismo e 
ipotiroidsmo 
trattati,acromegalia,gotta,mal 
reumatoide 
Glicemia lievemente 
aumentata,glucosio urinario 
presente,diabete controll da 
terapia orale,ormonoterpia,gotta 
attiva 
Diabete instabile con terapia 
orale 
Nefropatia diabetica 
Stato nutrizionale normale Malnutrizione lieve;albumina 
30-35 gr/l,decremento di peso 
<2.5 kg/m 
Malnutrizione moderata;albumina 
<30 gr/l,decremento di peso <2.5 
-5 kg/m 
cachessia 
Glasgow Coma Score 15 12-14 9-11 = o <8 
Ferita operatoria Minore/tempo operatorio < 2 
h/emorragia<300 ml 
Moderata/tempo operatorio 2-4 
h/emorragia300-500 ml 
Maggiore /tempo operatorio >4 
h/emorragia>500 
ml/escissionne di tumore 
Maggiore/escissione > 3 
organi/malattia tumorale non 
resecabile l
M Possum quadro 1 
indice 0 1 2 3 4 
età <60 60-69 70-79 >80 
Sist circolatorio Normale:funz.c 
ardiaca,PA,ECG 
Funz cardiaca 
grado 1:lieve 
ipertens e 
anormalità 
ECG,bradicardia 
o 
tachic,sinoatrial 
e,basso 
voltaggio 
derivaz arti 
inf,BBB 
Funz cardiaca 
grado 
2:moderata 
ipertens 
controllata da 
terapia,extrasis 
toli atriale 
occasionali 
Funz.cardiaca 
grado 3:IM<3 
mesi,ipertens 
moderata in 
terapia,ritmi 
ectopici,modific 
az ST-T, 
fibrillaz.atrial 
e. 
Insufficienza 
cardiaca 
seria,ins.cardiac 
a 
acuta,malattia 
ipertensiva 
Sist.respiratorio normale Fumo di 
vecchia 
data,bronchite 
cronica,asma,in 
fezioni 
respiratorie,stri 
e polmonari 
,ispessimenti 
Modesta 
COPD,modesta 
alteraz.funz.res 
p,modesto 
enfisema 
Moderata 
COPD,funz resp 
da moderata a 
seriamente 
anormale 
Insufficienza 
respiratoria
M Possum quadro 2 
0 1 2 3 4 
Funz.epatica normale Storia di 
epatite/cirrosi, 
bilirub 
tot.<34,2 
mmol/l 
bilirub 
tot.34,2-51.3 
mmol/l 
bilirub 
tot.>51.3 
mmol/l 
Funz.renale normale BUN<10.1 
mmol/lt,Creati 
nin.<170 
mmol/l 
BUN 10.1-15 
mmol/lt,creat 
170-300 
mmol/l 
Insuff renale in 
dialisi 
Tratto 
gastrointesti 
nale 
normale Storia di 
gastroenterite 
cronica,ulcera 
peptica ben 
controllata 
Malattia 
gastrointest 
attiva/emorrag 
ia/perforaz di 
ulcera,m.di 
Crohn. attiva 
Fistola 
intest.percutan 
ea 
Sindr.intestino 
corto,trapianto 
di intestino
M Possum quadro 3 
0 1 2 3 4 
ematopoiet 
ico 
normale Piastrine /GB 
lievemente 
diminuiti,HB 
>85 gr/l 
Malattia,co 
me 
leucemia 
,stabile;GB>1 
4.5 *109/l 
Mal.aplastica 
,sindr da 
ipersplenism 
o,leucemia,e 
cc. 
endocrino normale Glicemia 
lievemente 
aumentata,gl 
ucosio 
urinario 
assente,ipert 
iroidismo e 
ipotiroidsmo 
trattati,acro 
megalia,gott 
a,mal 
reumatoide 
Glicemia 
lievemente 
aumentata,gl 
ucosio 
urinario 
presente,dia 
bete controll 
da terapia 
orale,ormon 
oterpia,gotta 
attiva 
Diabete 
instabile con 
terapia orale 
Nefropatia 
diabetica
M Possum (quadro 4) 
0 1 2 3 4 
Stato 
nutrizionale 
normale Malnutrizione 
lieve;albumina 30- 
35 
gr/l,decremento 
di peso <2.5 kg/m 
Malnutrizione 
moderata;albumi 
na <30 
gr/l,decremento 
di peso <2.5 -5 
kg/m 
cachessia 
Glasgow 
Coma Score 
15 12-14 9-11 = o <8 
Ferita 
operatoria 
Minore/tempo 
operatorio < 2 
h/emorragia<300 
ml 
Moderata/tempo 
operatorio 2-4 
h/emorragia300- 
500 ml 
Maggiore /tempo 
operatorio >4 
h/emorragia>500 
ml/escissionne di 
tumore maligno 
Maggiore/escissio 
ne > 3 
organi/malattia 
tumorale non 
resecabile l 
Decorso 
anestetico 
Aritmia/bassa PA 
< 30 min 
PA sempre 
bassa,rianimazion 
e 
cardiopolmonare
Ding LA, Sun LQ, Chen SX, Qu LL, Xie DF. Modified 
physiological and operative score for the enumeration of 
mortality and morbidity risk assessment model in general 
surgery. World J Gastroenterol 2007; 13(38): 5090-5095
Predictive formula of M POssum 
• Logistic regression analysis yielded statistically signifi 
cant equations for both morbidity and mortality. 
• The morbidity equation was : 
lnR/1-R = -7.287 + 0.765M-POSSUM (P =0.000) 
• the mortality equation was: 
lnR/1-R = -10.000 + 0.681M-POSSUM (P = 0.000). 
The predictive accuracy of morbidity equation and 
mortality equation was 83.6% and 94.1%, respectively
O-POSSUM Score 
observed 30-day morbidity rate 58% 
Obs. Mortality 12% 
observed 1-year mortality 38% for males (mean age 79 years) and 29% for 
females (mean age 84 years). 
N Z Med J. 2006 May 19;119(1234):U1986. Comment in: 
N Z Med J. 2006;119(1234):U1981. Audit of morbidity and mortality 
following neck of femur fracture using the POSSUM scoring system. 
Young W, Seigne R, Bright S, Gardner M
Malnutrition Universal Screening Tool (MUST) 
‘MUST’ is a five-step screening tool to identify adults, who are malnourished, at risk of 
malnutrition, or obese. It also includes management guidelines which can be used 
to develop a care plan. The tool is being used both in hospitals and in the 
community. It is easy to use and can be used by all care workers. 
• Full details of this tool can be found at the following: 
• http://www.bapen.org.uk/the-must.htm 
• Calculate Risk 
• Use the form below to estimate the risk of malnutrition. Please note that the 
figures entered for weight must be in kilograms and the figure entered for height 
must be in centimetres. Conversion charts for Imperial units can be found here 
(opens in a new window). 
• Parameters Current weight (Kg) /Current height (cms) /Previous healthy weight* 
/Is the patient acutely ill and there has been or is likely to be no nutritional intake 
for >5 days? / 
• * This is the patients' weight when they were healthy, or the weight prior to any 
unplanned weight loss in the last 3-6 months
Application of Portsmouth modification of physiological and operative severity scoring 
system for enumeration of morbidity and mortality (P-POSSUM) in pancreatic surgery 
Appou Tamijmarane*, Chandra S Bhati, Darius F Mirza, Simon R Bramhall, 
David A Mayer, Stephen J Wigmore and John AC Buckels.World Journal of Surgical 
Oncology • 2008, 6:39 doi:10.1186/1477-7819-6-39 Abstract Background: Pancreatoduodenectomy (PD) is associated with high incidence of 
morbidity and mortality. We have applied P-POSSUM in predicting the incidence of outcome 
after PD to identify those who are at the highest risk of developing complications. 
• Method: A prospective database of 241 consecutive patients who had PD from January 
2002 to September 2005 was retrospectively updated and analysed. P-POSSUM score was 
calculated for each patient and correlated with observed morbidity and mortality. 
• Results: 30 days mortality was 7.8% and morbidity was 44.8%. Mean physiological score 
was 16.07 ± 3.30. Mean operative score was 13.67 ± 3.42. Mean operative score rose to 
20.28 ± 2.52 for the complex major operation (p < 0.001) with 2 fold increase in morbidity 
and 3.5 fold increase in mortality. For groups of patients with a physiological score of (less 
than or equal to) 18, the O:P 
• (observed to Predicted) morbidity ratio was 1.3–1.4 and, with a physiological score of >18, 
the O:P ratio was nearer to 1. Physiological score and white cell count were significant in a 
multivariate model. 
• Conclusion: P-POSSUM underestimated the mortality rate. While P-POSSUM analysis gave 
a truer prediction of morbidity, underestimation of morbidity and potential for systematic 
inaccuracy in prediction of complications at lower risk levels is a significant issue for 
pancreatic surgery.
E-PASS scoring 
Estimation of physiologic ability 
and surgical stress
• Estimation of Physiologic Ability and 
Surgical Stress (E-PASS) scoring 
system: 
• E-PASS=a pre-operative risk score (PRS), a 
surgical stress score (SSS), and a 
comprehensive risk score (CRS), which is 
calculated from the PRS and SSS. 
• CRS=PRS+SSS 
• E-PASS=K*CRS
equations of the E-PASS scoring 
system 
• The equations of the E-PASS scoring system are as follows (data from Haga et al1): 
(1) Estimation of physiologic ability and surgical stress (E-PASS) 
as a predictor of immediate outcome after elective 
abdominal aortic aneurysm surgery
equations of the E-PASS scoring system are as follows (data from 
Haga et al1): 
• (1) PRS = -0.0686 + 0.00345X1 +0.323X2 
+0.205X3 
+0.153X4 +0.148X5 +0.0666X6, 
where X1 is age; X2, the presence (1) or absence 
(0) of severe heart disease; X3, the presence (1) 
or absence (0) of severe pulmonary disease; X4, 
the presence (1) or absence (0) of diabetes 
mellitus; X5, the performance status index 
(range, 0-4); and X6, the American Society of 
Anesthesiologists' physiological status 
classification (range, 1-5).
• (1) PRS = -0.0686 + 0.00345X1 +0.323X2 
+0.205X3 
+0.153X4 +0.148X5 +0.0666X6, 
dove: X1 è etò, X2,la presenza (1) o assenza (0) 
di malattia cardiaca severa; X3 
la presenza (1) o 
assenza (0)di malattia polmonare severa; X4, la 
presenza (1) o assenza (0) di diabete mellitus; 
X5, il performance status index (range, 0-4); X6, 
la classificazione di stato fisico della American 
Society of Anesthesiologists (ASA Ps) (range, 1- 
5).
• Severe heart disease is defined as heart failure of New York Heart 
Association class III or IV or severe arrhythmia requiring mechanical 
support. 
• Severe pulmonary disease is defined as any condition with a percentage 
vital capacity of less than 60% and/or a percentage forced expiratory 
volume in 1 second of less than 50%. 
• Diabetes mellitus is defined according to the World Health Organization 
criteria. 
• Performance status index is defined by the Japanese Society for Cancer 
Therapy.
SSS:surgical stress core 
• (2) SSS = -0.342 + 0.0139X1 +0.0392X2 +0.352X3, 
where X1 is blood loss (in grams) divided by 
body weight (in kilograms); X2, the operating 
time (in hours); and X3, the extent of the skin 
incision (0 indicates a minor incision for 
laparoscopic or thoracoscopic surgery, 
including laparoscopic- or thoracoscopic-assisted 
surgery; 1, laparotomy or 
thoracotomy alone; and 2, laparotomy and 
thoracotomy). 
(
• 2) SSS = -0.342 + 0.0139X1 +0.0392X2 +0.352X3, 
dove X1 è la perdita ematica (in grammi) diviso 
per il peso corporeo (in kg); X2, tempo 
operatorio ( h); X3, l’estensione della incisione 
cutanea: (0 indica una incisione minore 
laparoscopica o toracoscopica; 1, laparotomia 
o toracototomia da sole ; 2, laparotomia e 
toracotomia
comprehensive risk score (CRS) 
• 3) CRS = -0.328 + (0.936 x PRS) + (0.976 x SSS).
Esempio di di EPass 
• 70 anni 
• Copd 
• Iperteso 
• Gastrect 5 h,perdite 800 ml stimate……. 
• PRS = -0.0686 + 0.00345*70+0.323*0 
+0.205*1 +0.153X4 
+0.148*??X5 +0.0666*3,assumiamo X5=1… 
• PRS=3,49 
• SSS =0,4345 
• CRS = -0.328 + (3,26) + (0,4240).=3,35 ,cioè mortalità 
0-5%,morbilità 44%
Incidence of mortality and morbidity accordingto CRS. The graph appears to 
demonstrate that patients in the ≥1.0 categoryare at particularly high risk 
of mortality, and in the .5 to <1.0 and ≥1.0categories at particularly high risk 
of morbidity. Bars show 95% confidence intervals Estimation of physiologic ability and 
surgical stress (E-PASS) as a predictor of immediate outcome after elective abdominal aortic aneurysm 
surgery
Estimation of physiologic ability and surgical stress (E-PASS) as a predictor of immediate outcome after 
elective abdominal aortic aneurysm surgery
Br J Surg. 2007 Jun;94(6):717-21. Comment in: 
Br J Surg. 2007 Oct;94(10):1308; author reply 1308-9. VBHOM, a data economic 
model for predicting the outcome after open abdominal aortic aneurysm surgery. 
Tang T, Walsh SR, Prytherch DR, Lees T, Varty K, Boyle JR; 
Audit Research Committee of the Vascular Society of Great Britain and Ireland. 
• BACKGROUND: Vascular Biochemistry and Haematology Outcome Models (VBHOM) 
adopted the approach of using a minimum data set to model outcome. This study 
aimed to test such a model on a cohort of patients undergoing open elective and non-elective 
abdominal aortic aneurysm (AAA) repair. METHODS: A binary logistic 
regression model of risk of in-hospital mortality was built from the 2002-2004 
submission to the UK National Vascular Database (NVD) (2718 patients). The subset of 
NVD data items used comprised serum levels of urea, sodium and potassium, 
haemoglobin, white cell count, sex, age and mode of admission. The model was applied 
prospectively using Hosmer-Lemeshow methodology to a test data set from the 
Cambridge Vascular Unit. RESULTS: The validation set contained 327 patients, of whom 
208 had elective AAA repair and 119 had emergency repair of a ruptured AAA. 
Outcome following elective and non-elective AAA repair could be described accurately 
using the same model. The overall mean predicted risk of death was 14.13 per cent, 
and 48 deaths were predicted. The actual number of deaths was 53 (chi(2) = 8.40, 10 
d.f., P = 0.590; no evidence of lack of fit). The model also demonstrated good 
discrimination (c-index = 0.852). CONCLUSION: The VBHOM approach has the 
advantage of using simple, objective clinical data that are easy to collect routinely. The 
VBHOM data items potentially allow prediction of risk in an individual patient before 
aneurysm surgery. (c) 2007 British Journal of
Vascular Biochemistry and Haematology Outcome 
Models (VBHOM) 
• serum levels of: 
– urea, 
–sodium and potassium, 
–haemoglobin, 
–white cell count, 
–sex, 
–age 
– mode of admission.
Eur J Vasc Endovasc Surg. 2007 Nov;34(5):505-13. Epub 2007 Sep 14. Links 
Comment in: Eur J Vasc Endovasc Surg. 2007 Nov;34(5):497-8. Comparison of risk-scoring 
methods in predicting the immediate outcome after elective open abdominal aortic 
aneurysm surgery. 
Tang TY, Walsh SR, Fanshawe TR, Seppi V, Sadat U, Hayes PD, Varty K, Gaunt ME, Boyle 
JR. 
• BACKGROUND & OBJECTIVES: The aim of this study was to apply three simple risk - scoring 
systems to prospectively collected data on all elective open Abdominal Aortic Aneurysm (AAA) 
operations in the Cambridge Academic Vascular Unit over a 6 - year period (January 1998 to 
January 2004), to compare their predictive values and to evaluate their validity with respect to 
prediction of mortality and post-operative complications. METHODS: 204 patients underwent 
elective open infra-renal AAA repair. Data were prospectively collected and risk assessment scores 
were calculated for mortality and morbidity according to the Glasgow Aneurysm Score (GAS), 
VBHOM (Vascular Biochemistry and Haematology Outcome Models) and Estimation of Physiologic 
Ability and Surgical Stress (E-PASS). RESULTS: The mortality rate was 6.3% (13/204) and 59% 
(121/204) experienced a post-operative complication (30-day outcome). For GAS, VBHOM and E-PASS 
the receiver operating characteristics (ROC) curve analysis for prediction of in-hospital 
mortality showed area under the curve (AUC) of 0.84 (95% confidence interval [CI], 0.76 to 0.92; 
p<0.0001), 0.82 (95% CI, 0.68 to 0.95; p=0.0001) and 0.92 (95% CI, 0.87 to 0.97; p<0.0001) 
respectively. There were also significant correlations between post-operative complications and 
length of hospital stay and each of the three scores, but the correlation was substantially higher in 
the case of E-PASS. CONCLUSIONS: All three scoring systems accurately predicted the risk of 
mortality and morbidity in patients undergoing elective open AAA repair. Among these, E-PASS 
seemed to be the most accurate predictor in this patient population.
Eur J Vasc Endovasc Surg. 2008 Oct 13. [Epub ahead of print] Links 
Predicting Risk in Elective Abdominal Aortic Aneurysm Repair: A 
Systematic Review of Current Evidence. 
Patterson BO, Holt PJ, Hinchliffe R, Loftus IM, Thompson MM 
• . OBJECTIVE: To examine and compare existing pre-operative risk prediction methods for 
elective abdominal aortic aneurysm (AAA) repair. DESIGN: Systematic review. METHODS: 
Medline, EMBASE and the Cochrane library were searched for articles that related to risk 
prediction models used for elective AAA repair. RESULTS: 680 abstracts were reviewed 
and after exclusions 28 articles encompassing 10 risk models were identified. The most 
frequently studied of these were the Glasgow Aneurysm Score (GAS), the Physiological 
and Operative Severity Score for enUmeration of Mortality (POSSUM) predictor equation 
and the Vascular Biochemistry and Haematology Outcome Model (VBHOM). All models 
had strengths and weaknesses and some had unique features which were identified and 
discussed. CONCLUSION: The GAS appeared to be the most useful and consistently 
validated score at present for open repair. Other systems were either not validated fully 
or were not consistently accurate. Some had significant drawbacks which appeared to 
severely limit their clinical application. Recent work has shown that no scores 
consistently predicted the risk associated with endovascular aneurysm repair (EVAR). Pre-operative 
risk stratification is a vital component of modern surgical practice, and we 
propose the need for a comprehensive new risk scoring method for AAA repair 
incorporating anatomical and physiological data.
Surgical Apgar score
Surgical Apgar Score 
Regenbogen, Scott E. MD, MPH *+; Lancaster, R Todd MD *+; Lipsitz, Stuart R. ScD ++; Greenberg, Caprice 
C. MD, MPH ++; Hutter, Matthew M. MD, MPH +; Gawande, Atul A. MD, MPH *++ Does the Surgical Apgar 
Score Measure Intraoperative Performance? Annals of Surgery. 248(2):320-328, August 2008. 
• lowest heart rate 
• lowest mean arterial pressure 
• estimated blood loss 
• A score built from these 3 predictors has proved 
strongly predictive of the risk of major postoperative 
complications and death in general and vascular surgery. 
• The score was thus developed using these 3 variables, and their beta coefficients 
were used to weight the points allocated to each variable in a 10-point score 
(Table 1).
Regenbogen, Scott E. MD, MPH *+; Lancaster, R Todd MD *+; Lipsitz, Stuart R. ScD ++; 
Greenberg, Caprice C. MD, MPH ++; Hutter, Matthew M. MD, MPH +; Gawande, Atul 
A. MD, MPH *++ Does the Surgical Apgar Score Measure Intraoperative Performance? 
Annals of Surgery. 248(2):320-328, August 2008.
Regenbogen, Scott E. MD, MPH *+; Lancaster, R Todd MD *+; Lipsitz, Stuart R. ScD ++; 
Greenberg, Caprice C. MD, MPH ++; Hutter, Matthew M. MD, MPH +; Gawande, Atul 
A. MD, MPH *++ Does the Surgical Apgar Score Measure Intraoperative Performance? 
Annals of Surgery. 248(2):320-328, August 2008.
Regenbogen, Scott E. MD, MPH *+; Lancaster, R Todd MD *+; Lipsitz, Stuart R. ScD ++; 
Greenberg, Caprice C. MD, MPH ++; Hutter, Matthew M. MD, MPH +; Gawande, Atul 
A. MD, MPH *++ Does the Surgical Apgar Score Measure Intraoperative Performance? 
Annals of Surgery. 248(2):320-328, August 2008.
Regenbogen, Scott E. MD, MPH *+; Lancaster, R Todd MD *+; Lipsitz, Stuart R. ScD ++; 
Greenberg, Caprice C. MD, MPH ++; Hutter, Matthew M. MD, MPH +; Gawande, Atul 
A. MD, MPH *++ Does the Surgical Apgar Score Measure Intraoperative Performance? 
Annals of Surgery. 248(2):320-328, August 2008.
Frequenza delle complicanze a seconda del Surgical Apgar 
Score 
Regenbogen, Scott E. MD, MPH *+; Lancaster, R Todd MD *+; Lipsitz, Stuart R. ScD ++; Greenberg, Caprice C. 
MD, MPH ++; Hutter, Matthew M. MD, MPH +; Gawande, Atul A. MD, MPH *++ Does the Surgical Apgar 
Score Measure Intraoperative Performance? Annals of Surgery. 248(2):320-328, August 2008. 
80 
70 
60 
50 
40 
30 
20 
10 
0 
Ko maggiori 
0-2 
3-4 
5-6 
7-8 
9-10 
%
Apache III 
• the APACHE III is used to produce an equation predicting hospital mortality 
after the first day of ICU treatment. There are 4 components: age, major 
disease category (reason for ICU admission), acute (current) physiology, and 
prior site of healthcare (eg, hospital floor, emergency room, etc.). The 
physiologic variables require scoring of the following vital sign and laboratory 
abnormalities: pulse rate, mean blood pressure, temperature, respiratory rate, 
PaO2/P (A-a) O2, hematocrit, white blood cell count, creatinine, urine output, 
blood urea nitrogen, serum sodium, albumin, bilirubin, glucose, acid-base 
status, and neurologic status. 
• The last 2 physiologic parameters are hybrid values specific to APACHE III.[3] It is 
important to note that an additional scoring variable must be used to update 
the APACHE III score based on changes in the patient's physiologic status.
references 
• Knaus WA, Draper EA, Wagner DP it al. APACHE II: A severity of disease 
classification system. Crit Care Med. 1985;13:818-829. 
• Le Gall Jr, Lemeshow S, Saulnier F. A new Simplified Acute Physiology 
Score (SAPS II) based on a European/North American multicenter study. 
JAMA. 1993;270:2957-2963. 
• Knaus WA, Wagner DP, Draper EA et al. The APACHE III Prognostic System. 
Chest. 1991;100:1619-1636. 
• Beck DH, Taylor BL, Millar B, et al. Prediction of outcome from intensive 
care: A prospective cohort study comparing Acute Physiology and Chronic 
Health Evaluation II and III prognostic systems in a United Kingdom 
intensive care unit. Crit Care Med. 1997;25:9-15.
Apache II score
Saps II score
Sofa score
Comparison of the performance of SAPS II, SAPS 3, APACHE II, and their 
customized prognostic models in a surgical intensive care unit 
Y. Sakr1, C. Krauss1, A. C. K. B. Amaral2, A. Réa-Neto2, M. Specht1, K. Reinhart1 and 
G. Marx1 
• We compared the performance of SAPS 3 with SAPS II and the Acute Physiology and Chronic 
Health Evaluation (APACHE) II score in surgical ICU patients. 
• Methods: Prospectively collected data from all patients admitted to a German university 
hospital postoperative ICU between August 2004 and December 2005 were analysed. The 
probability of ICU mortality was calculated for SAPS II, APACHE II, adjusted APACHE II (adj- 
APACHE II), SAPS 3, and SAPS 3 customized for Europe [C-SAPS3 (Eu)] using standard 
formulas. To improve calibration of the prognostic models, a first-level customization was 
performed, using logistic regression on the original scores, and the corresponding probability 
of ICU death was calculated for the customized scores (C-SAPS II, C-SAPS 3, and C-APACHE II). 
• Results: The study included 1851 patients. Hospital mortality was 9%. Hosmer and Lemeshow 
statistics showed poor calibration for SAPS II, APACHE II, adj-APACHE II, SAPS 3, and C-SAPS 3 
(Eu), but good calibration for C-SAPS II, C-APACHE II, and C-SAPS 3. Discrimination was 
generally good for all models [area under the receiver operating characteristic curve ranged 
from 0.78 (C-APACHE II) to 0.89 (C-SAPS 3)]. The C-SAPS 3 score appeared to have the best 
calibration curve on visual inspection. 
• Conclusions: In this group of surgical ICU patients, the performance of SAPS 3 was similar to 
that of APACHE II and SAPS II. Customization improved the calibration of all prognostic 
models.
Comparison of Apache II,Saps and Sofa scores
Calculations of risk scores

Weitere ähnliche Inhalte

Was ist angesagt?

Enhanced Recovery After Surgery
Enhanced Recovery After SurgeryEnhanced Recovery After Surgery
Enhanced Recovery After SurgeryRobiul Karim
 
Enhanced recovery after surgery (eras)
Enhanced recovery after surgery (eras)Enhanced recovery after surgery (eras)
Enhanced recovery after surgery (eras)Dr. Tanmoy Roy
 
Toilet mastectomy for advanced breast cancer.
Toilet mastectomy for advanced breast cancer.Toilet mastectomy for advanced breast cancer.
Toilet mastectomy for advanced breast cancer.KETAN VAGHOLKAR
 
ERAS Protocol
ERAS ProtocolERAS Protocol
ERAS Protocolankit0019
 
Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantationSouvik Maitra
 
The Surgery for Rectal Cancer
The Surgery for Rectal CancerThe Surgery for Rectal Cancer
The Surgery for Rectal Cancerensteve
 
Guidelines on massive blood transfusion(lecture-6)
Guidelines on massive blood transfusion(lecture-6)Guidelines on massive blood transfusion(lecture-6)
Guidelines on massive blood transfusion(lecture-6)charithwg
 
Overview of liver transplantation
Overview of liver transplantationOverview of liver transplantation
Overview of liver transplantationhr77
 
Hepatectomy anaesthesia
Hepatectomy anaesthesia Hepatectomy anaesthesia
Hepatectomy anaesthesia Kiran Rajagopal
 
Whipple's procedure - Indications, Steps, Complications
Whipple's procedure - Indications, Steps, ComplicationsWhipple's procedure - Indications, Steps, Complications
Whipple's procedure - Indications, Steps, ComplicationsVikas V
 
Oncoplastic breast surgery
Oncoplastic breast surgeryOncoplastic breast surgery
Oncoplastic breast surgeryKundan Singh
 
Open right hemicolectomy/ step by step/ operative surgery
Open right hemicolectomy/ step by step/ operative surgeryOpen right hemicolectomy/ step by step/ operative surgery
Open right hemicolectomy/ step by step/ operative surgerySelvaraj Balasubramani
 
TEG - Thromboelastography
TEG - ThromboelastographyTEG - Thromboelastography
TEG - ThromboelastographyMohtasib Madaoo
 
Principles of vascular anastomosis
Principles of vascular anastomosisPrinciples of vascular anastomosis
Principles of vascular anastomosisAbdulsalam Taha
 
Fluid management in surgical patients
Fluid  management in surgical patientsFluid  management in surgical patients
Fluid management in surgical patientsGovtRoyapettahHospit
 
Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies
Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface MalignanciesHyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies
Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface MalignanciesMary Ondinee Manalo Igot
 

Was ist angesagt? (20)

Esophagectomy
Esophagectomy Esophagectomy
Esophagectomy
 
Enhanced Recovery After Surgery
Enhanced Recovery After SurgeryEnhanced Recovery After Surgery
Enhanced Recovery After Surgery
 
Perioperative fluid management
Perioperative fluid managementPerioperative fluid management
Perioperative fluid management
 
Enhanced recovery after surgery (eras)
Enhanced recovery after surgery (eras)Enhanced recovery after surgery (eras)
Enhanced recovery after surgery (eras)
 
Toilet mastectomy for advanced breast cancer.
Toilet mastectomy for advanced breast cancer.Toilet mastectomy for advanced breast cancer.
Toilet mastectomy for advanced breast cancer.
 
ERAS Protocol
ERAS ProtocolERAS Protocol
ERAS Protocol
 
Anaesthesia for renal transplantation
Anaesthesia for renal transplantationAnaesthesia for renal transplantation
Anaesthesia for renal transplantation
 
The Surgery for Rectal Cancer
The Surgery for Rectal CancerThe Surgery for Rectal Cancer
The Surgery for Rectal Cancer
 
Guidelines on massive blood transfusion(lecture-6)
Guidelines on massive blood transfusion(lecture-6)Guidelines on massive blood transfusion(lecture-6)
Guidelines on massive blood transfusion(lecture-6)
 
Overview of liver transplantation
Overview of liver transplantationOverview of liver transplantation
Overview of liver transplantation
 
Hepatectomy anaesthesia
Hepatectomy anaesthesia Hepatectomy anaesthesia
Hepatectomy anaesthesia
 
Whipple's procedure - Indications, Steps, Complications
Whipple's procedure - Indications, Steps, ComplicationsWhipple's procedure - Indications, Steps, Complications
Whipple's procedure - Indications, Steps, Complications
 
Oncoplastic breast surgery
Oncoplastic breast surgeryOncoplastic breast surgery
Oncoplastic breast surgery
 
Open right hemicolectomy/ step by step/ operative surgery
Open right hemicolectomy/ step by step/ operative surgeryOpen right hemicolectomy/ step by step/ operative surgery
Open right hemicolectomy/ step by step/ operative surgery
 
Stents in surgery
Stents in surgeryStents in surgery
Stents in surgery
 
TEG - Thromboelastography
TEG - ThromboelastographyTEG - Thromboelastography
TEG - Thromboelastography
 
Ppp pneumoperitoneum
Ppp pneumoperitoneumPpp pneumoperitoneum
Ppp pneumoperitoneum
 
Principles of vascular anastomosis
Principles of vascular anastomosisPrinciples of vascular anastomosis
Principles of vascular anastomosis
 
Fluid management in surgical patients
Fluid  management in surgical patientsFluid  management in surgical patients
Fluid management in surgical patients
 
Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies
Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface MalignanciesHyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies
Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies
 

Ähnlich wie Calculations of risk scores

NY Prostate Cancer Conference - K. Touijer - Session 4: Predicting clinical a...
NY Prostate Cancer Conference - K. Touijer - Session 4: Predicting clinical a...NY Prostate Cancer Conference - K. Touijer - Session 4: Predicting clinical a...
NY Prostate Cancer Conference - K. Touijer - Session 4: Predicting clinical a...European School of Oncology
 
DU PERF SCORING
DU PERF SCORINGDU PERF SCORING
DU PERF SCORINGNHS
 
NY Prostate Cancer Conference - A. Stephenson - Session 4: Predicting clinica...
NY Prostate Cancer Conference - A. Stephenson - Session 4: Predicting clinica...NY Prostate Cancer Conference - A. Stephenson - Session 4: Predicting clinica...
NY Prostate Cancer Conference - A. Stephenson - Session 4: Predicting clinica...European School of Oncology
 
i.a.Preoperative ovarian cancer diagnosis using neuro fuzzy approach
i.a.Preoperative ovarian cancer diagnosis using neuro fuzzy approachi.a.Preoperative ovarian cancer diagnosis using neuro fuzzy approach
i.a.Preoperative ovarian cancer diagnosis using neuro fuzzy approachJonathan Josue Cid Galiot
 
Health economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development processHealth economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development processcheweb1
 
Validation of a 46 gene expression signature in early-stage non-small-cell lu...
Validation of a 46 gene expression signature in early-stage non-small-cell lu...Validation of a 46 gene expression signature in early-stage non-small-cell lu...
Validation of a 46 gene expression signature in early-stage non-small-cell lu...MyriadGenetics
 
Deciphering the 2014 AHA perioperative managment guidlines
Deciphering the 2014 AHA perioperative managment guidlinesDeciphering the 2014 AHA perioperative managment guidlines
Deciphering the 2014 AHA perioperative managment guidlinesAmr Moustafa Kamel
 
Evaluation of POSSUM scoring system in patients with perforation peritonitis ...
Evaluation of POSSUM scoring system in patients with perforation peritonitis ...Evaluation of POSSUM scoring system in patients with perforation peritonitis ...
Evaluation of POSSUM scoring system in patients with perforation peritonitis ...Kundan Singh
 
Thesis work updated.pptx
Thesis work updated.pptxThesis work updated.pptx
Thesis work updated.pptxNehaMasarkar1
 
NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...
NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...
NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...European School of Oncology
 
Pre operative assessment & optimization in CLD for non transplant surgery
Pre operative assessment & optimization in CLD for non transplant surgeryPre operative assessment & optimization in CLD for non transplant surgery
Pre operative assessment & optimization in CLD for non transplant surgeryDr. Rohit Saini
 
Prostate cancer molecular bio markers seminar
Prostate cancer molecular bio markers seminarProstate cancer molecular bio markers seminar
Prostate cancer molecular bio markers seminarHarshaR35
 
Optimization of DCE-MRI measurement parameters for predicting response to neo...
Optimization of DCE-MRI measurement parameters for predicting response to neo...Optimization of DCE-MRI measurement parameters for predicting response to neo...
Optimization of DCE-MRI measurement parameters for predicting response to neo...Wen Li
 
Esc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronaryEsc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronaryHimanshu Rana
 

Ähnlich wie Calculations of risk scores (20)

NY Prostate Cancer Conference - K. Touijer - Session 4: Predicting clinical a...
NY Prostate Cancer Conference - K. Touijer - Session 4: Predicting clinical a...NY Prostate Cancer Conference - K. Touijer - Session 4: Predicting clinical a...
NY Prostate Cancer Conference - K. Touijer - Session 4: Predicting clinical a...
 
E pass scoring
E pass scoringE pass scoring
E pass scoring
 
DU PERF SCORING
DU PERF SCORINGDU PERF SCORING
DU PERF SCORING
 
NY Prostate Cancer Conference - A. Stephenson - Session 4: Predicting clinica...
NY Prostate Cancer Conference - A. Stephenson - Session 4: Predicting clinica...NY Prostate Cancer Conference - A. Stephenson - Session 4: Predicting clinica...
NY Prostate Cancer Conference - A. Stephenson - Session 4: Predicting clinica...
 
i.a.Preoperative ovarian cancer diagnosis using neuro fuzzy approach
i.a.Preoperative ovarian cancer diagnosis using neuro fuzzy approachi.a.Preoperative ovarian cancer diagnosis using neuro fuzzy approach
i.a.Preoperative ovarian cancer diagnosis using neuro fuzzy approach
 
06 Hizoh aimradial20170921 Mortality risk
06 Hizoh aimradial20170921 Mortality risk06 Hizoh aimradial20170921 Mortality risk
06 Hizoh aimradial20170921 Mortality risk
 
Health economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development processHealth economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development process
 
Stein cimt for shape 11-05
Stein   cimt for shape 11-05Stein   cimt for shape 11-05
Stein cimt for shape 11-05
 
Validation of a 46 gene expression signature in early-stage non-small-cell lu...
Validation of a 46 gene expression signature in early-stage non-small-cell lu...Validation of a 46 gene expression signature in early-stage non-small-cell lu...
Validation of a 46 gene expression signature in early-stage non-small-cell lu...
 
Deciphering the 2014 AHA perioperative managment guidlines
Deciphering the 2014 AHA perioperative managment guidlinesDeciphering the 2014 AHA perioperative managment guidlines
Deciphering the 2014 AHA perioperative managment guidlines
 
Evaluation of POSSUM scoring system in patients with perforation peritonitis ...
Evaluation of POSSUM scoring system in patients with perforation peritonitis ...Evaluation of POSSUM scoring system in patients with perforation peritonitis ...
Evaluation of POSSUM scoring system in patients with perforation peritonitis ...
 
Thesis work updated.pptx
Thesis work updated.pptxThesis work updated.pptx
Thesis work updated.pptx
 
Factors Predict Perioperative Morbidity pancreatic resection
Factors Predict Perioperative Morbidity pancreatic resectionFactors Predict Perioperative Morbidity pancreatic resection
Factors Predict Perioperative Morbidity pancreatic resection
 
Kwon et.al
Kwon et.alKwon et.al
Kwon et.al
 
NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...
NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...
NY Prostate Cancer Conference - J. Bellmunt - Panel discussion D: Do we need ...
 
Pre operative assessment & optimization in CLD for non transplant surgery
Pre operative assessment & optimization in CLD for non transplant surgeryPre operative assessment & optimization in CLD for non transplant surgery
Pre operative assessment & optimization in CLD for non transplant surgery
 
Spark classification
Spark classificationSpark classification
Spark classification
 
Prostate cancer molecular bio markers seminar
Prostate cancer molecular bio markers seminarProstate cancer molecular bio markers seminar
Prostate cancer molecular bio markers seminar
 
Optimization of DCE-MRI measurement parameters for predicting response to neo...
Optimization of DCE-MRI measurement parameters for predicting response to neo...Optimization of DCE-MRI measurement parameters for predicting response to neo...
Optimization of DCE-MRI measurement parameters for predicting response to neo...
 
Esc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronaryEsc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronary
 

Mehr von Claudio Melloni

Conscious sedation intero inglese pptx
Conscious sedation   intero inglese pptxConscious sedation   intero inglese pptx
Conscious sedation intero inglese pptxClaudio Melloni
 
Conscious sedation for moscow windows
Conscious sedation for moscow  windowsConscious sedation for moscow  windows
Conscious sedation for moscow windowsClaudio Melloni
 
Nora e reversal colorato slideshare; NaPoli i SIA 2016
Nora e reversal colorato slideshare; NaPoli i SIA 2016Nora e reversal colorato slideshare; NaPoli i SIA 2016
Nora e reversal colorato slideshare; NaPoli i SIA 2016Claudio Melloni
 
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...Claudio Melloni
 
Corso sul cisatracurium per glaxo 2007 ottobre
Corso sul cisatracurium per glaxo 2007 ottobreCorso sul cisatracurium per glaxo 2007 ottobre
Corso sul cisatracurium per glaxo 2007 ottobreClaudio Melloni
 
Update on NSAID's,Coxibs(2008???)
Update on NSAID's,Coxibs(2008???)Update on NSAID's,Coxibs(2008???)
Update on NSAID's,Coxibs(2008???)Claudio Melloni
 
Valut az rischio anest sia napoli dic 2008;italian + bibliografy
Valut az rischio anest sia napoli dic 2008;italian + bibliografyValut az rischio anest sia napoli dic 2008;italian + bibliografy
Valut az rischio anest sia napoli dic 2008;italian + bibliografyClaudio Melloni
 
Various surgical and anesthesiological risks
Various surgical and anesthesiological risksVarious surgical and anesthesiological risks
Various surgical and anesthesiological risksClaudio Melloni
 
Ryanodex,a new dantrolene formulation
Ryanodex,a new dantrolene formulation Ryanodex,a new dantrolene formulation
Ryanodex,a new dantrolene formulation Claudio Melloni
 
The traveling anesthesiologist
The traveling anesthesiologist The traveling anesthesiologist
The traveling anesthesiologist Claudio Melloni
 
Raccomandazioni val reope mal card pptx
Raccomandazioni  val reope mal card pptxRaccomandazioni  val reope mal card pptx
Raccomandazioni val reope mal card pptxClaudio Melloni
 
Raccomandazioni per la valutazione preoperatoria malattie remalii
Raccomandazioni  per la valutazione preoperatoria malattie remaliiRaccomandazioni  per la valutazione preoperatoria malattie remalii
Raccomandazioni per la valutazione preoperatoria malattie remaliiClaudio Melloni
 
Raccomandazioni per la val preop in chirurgia non cardiaca;pazienti diabetici
Raccomandazioni  per la val preop in chirurgia non cardiaca;pazienti diabetici Raccomandazioni  per la val preop in chirurgia non cardiaca;pazienti diabetici
Raccomandazioni per la val preop in chirurgia non cardiaca;pazienti diabetici Claudio Melloni
 
Raccomandazioni per la val preop mal resp
Raccomandazioni  per la val preop mal resp Raccomandazioni  per la val preop mal resp
Raccomandazioni per la val preop mal resp Claudio Melloni
 
Pulmonary complications risk
Pulmonary complications riskPulmonary complications risk
Pulmonary complications riskClaudio Melloni
 
Ponv corso itinerante 2008.
Ponv corso itinerante 2008.Ponv corso itinerante 2008.
Ponv corso itinerante 2008.Claudio Melloni
 
Obesity risk in anesthesia a nd surgery
Obesity risk in anesthesia a nd surgery Obesity risk in anesthesia a nd surgery
Obesity risk in anesthesia a nd surgery Claudio Melloni
 

Mehr von Claudio Melloni (20)

Conscious sedation intero inglese pptx
Conscious sedation   intero inglese pptxConscious sedation   intero inglese pptx
Conscious sedation intero inglese pptx
 
Conscious sedation for moscow windows
Conscious sedation for moscow  windowsConscious sedation for moscow  windows
Conscious sedation for moscow windows
 
Nora e reversal colorato slideshare; NaPoli i SIA 2016
Nora e reversal colorato slideshare; NaPoli i SIA 2016Nora e reversal colorato slideshare; NaPoli i SIA 2016
Nora e reversal colorato slideshare; NaPoli i SIA 2016
 
Are there limits to ga?
Are there limits to ga?Are there limits to ga?
Are there limits to ga?
 
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
 
Corso sul cisatracurium per glaxo 2007 ottobre
Corso sul cisatracurium per glaxo 2007 ottobreCorso sul cisatracurium per glaxo 2007 ottobre
Corso sul cisatracurium per glaxo 2007 ottobre
 
Update on NSAID's,Coxibs(2008???)
Update on NSAID's,Coxibs(2008???)Update on NSAID's,Coxibs(2008???)
Update on NSAID's,Coxibs(2008???)
 
Valut az rischio anest sia napoli dic 2008;italian + bibliografy
Valut az rischio anest sia napoli dic 2008;italian + bibliografyValut az rischio anest sia napoli dic 2008;italian + bibliografy
Valut az rischio anest sia napoli dic 2008;italian + bibliografy
 
Surgical apgar score
Surgical apgar scoreSurgical apgar score
Surgical apgar score
 
Various surgical and anesthesiological risks
Various surgical and anesthesiological risksVarious surgical and anesthesiological risks
Various surgical and anesthesiological risks
 
Ryanodex,a new dantrolene formulation
Ryanodex,a new dantrolene formulation Ryanodex,a new dantrolene formulation
Ryanodex,a new dantrolene formulation
 
The traveling anesthesiologist
The traveling anesthesiologist The traveling anesthesiologist
The traveling anesthesiologist
 
Raccomandazioni val reope mal card pptx
Raccomandazioni  val reope mal card pptxRaccomandazioni  val reope mal card pptx
Raccomandazioni val reope mal card pptx
 
Raccomandazioni per la valutazione preoperatoria malattie remalii
Raccomandazioni  per la valutazione preoperatoria malattie remaliiRaccomandazioni  per la valutazione preoperatoria malattie remalii
Raccomandazioni per la valutazione preoperatoria malattie remalii
 
Raccomandazioni per la val preop in chirurgia non cardiaca;pazienti diabetici
Raccomandazioni  per la val preop in chirurgia non cardiaca;pazienti diabetici Raccomandazioni  per la val preop in chirurgia non cardiaca;pazienti diabetici
Raccomandazioni per la val preop in chirurgia non cardiaca;pazienti diabetici
 
Raccomandazioni per la val preop mal resp
Raccomandazioni  per la val preop mal resp Raccomandazioni  per la val preop mal resp
Raccomandazioni per la val preop mal resp
 
Pulmonary complications risk
Pulmonary complications riskPulmonary complications risk
Pulmonary complications risk
 
Ponv corso itinerante 2008.
Ponv corso itinerante 2008.Ponv corso itinerante 2008.
Ponv corso itinerante 2008.
 
Ortopedic possum ppt
Ortopedic possum pptOrtopedic possum ppt
Ortopedic possum ppt
 
Obesity risk in anesthesia a nd surgery
Obesity risk in anesthesia a nd surgery Obesity risk in anesthesia a nd surgery
Obesity risk in anesthesia a nd surgery
 

Kürzlich hochgeladen

Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 

Kürzlich hochgeladen (20)

Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 

Calculations of risk scores

  • 1. Calculations of risk scores Possum e derivati,EPASS,VBHOM,surgical apgar,Saps,Apache,Sofa….
  • 2. • SAPS?? • APACHE??
  • 3. Risk prediction on line • Risk prediction in surgery [http://www.riskprediction.org.uk/p pindex.php]. • SFAR
  • 4. • This site has been developed to allow surgeons to estimate risk online for their patients undergoing surgery. This service is provided for individual use to help surgeons more fully consent their patients by giving mortality and other surgical risk predictions based on relevant prognostic factors including age, disease severity and co-morbidity. Risk adjusted operative mortality can be used as an objective measure of outcome for monitoring performance within a centre or between centres.
  • 5. Surgical Risk scores • ACPGBI CRC Model - Association of Coloproctology of GB & I Colorectal Cancer Model for mortality in colorectal cancer • ACPGBI MBO Model - Association of Coloproctology of GB & I model for mortality prediction in malignant bowel obstruction • ACPGBI Lymph Node Harvesting Model - Association of Coloproctology of GB & I model for determining the number of nodes that should be found in each resection • St Mark's Lymph Node Positivity Model - calculates the probability of lymph node metastases in patients undergoing local resection of rectal cancers and for patients whose nodal harvest was not sufficient to adequately stage the rectal cancer. • CCF CLC Model - The Cleveland Clinic Colorectal Laparoscopic Conversion Model for prediction of conversion of lapararoscopic to open surgery in patients undergoing colonic or rectal surgery for benign or malignant disease. • CCF IPF Model - The Cleveland Clinic Ileal Pouch Failure Model for prediction of ileal pouch failure in patients undergoing restorative proctocolectomy. • CR-POSSUM - Used for predicting mortality in Colorectal Surgery (benign & malignant) • P-POSSUM - Used for predicting mortality (& morbidity by POSSUM) in General Surgery • O-POSSUM - Used for predicting mortality in Oesophagogastric Surgery • Vascular-POSSUM - Used for predicting mortality in Vascular Surgery (all 4 models available • MUST screening tool (malnutrition)
  • 6. calculate a mortality risk online for patients using the ACPGBI Colorectal Cancer Model • Calculate an ACP Score • Choose a value in each category that matches your patient from the drop down lists in both the physiological and operative parameters tables below. Default values (the lowest score) are shown for each category. Simply submitting the form as it is without changing the values (i.e. a young fit patient having a minor operation) still gives a % risk for mortality. It is important to say in this model by ticking the appropriate box whether or not the cancer was resected. The reason for this is the value allocated to ASA status is dependent upon resection status. • Parameters – Age – Cancer Resection Status cancer resected cancer NOT resected – ASA Status C – Cancer Staging :Duke’s – Operative Urgency ;elective,urgent,emergency
  • 7. • POSSUM: • physiological and operative severity scoring system for enumeration of morbidity and mortality
  • 8. Calculate a CR-POSSUM Score • Choose a value in each category that matches your patient from the drop down lists in both the physiological and operative parameters tables below. Default values (the lowest score) are shown for each category. Simply submitting the form as it is without changing the values (i.e. a young fit patient having a minor operation) still gives a v.small % risk for mortality. The more 'risky' the procedure the more accurate is the predicted risk calculated below.
  • 9. CR POSSUM • Physiological Parameters – Age – Cardiac :No-mild/moderate Carcdiac failure/severe CF – Systolic BP – Pulse Rate – Haemoglobin – Urea • If calculating risk in a preoperative patient you will need to estimate the parameters below. You can return and modify the parameters post-operatively if required. – Operative Parameters – Operation Type • Peritoneal Contamination • Malignancy Status • CEPOD
  • 10. Calculate a P-POSSUM Score Choose a value in each category that matches your patient from the drop down lists in both the physiological and operative parameters tables below. Default values (the lowest score) are shown for each category. Simply submitting the form as it is without changing the values (i.e. a young fit patient having a minor operation) still gives a % risk for morbidity and mortality. This illustrates that even in the modified P-POSSUM formula used in this application still overestimates risk in low risk groups. The more 'risky' the procedure the more accurate is the predicted risk calculated below.
  • 11. P-POSSUM score Physiological Parameters Age Cardiac Respiratory ECG Systolic BP Pulse Rate Haemoglobin WBC Urea Sodium Potassium GCS I f calculating risk in a preoperative patient you will need to estimate the parameters below. You can return and modify the parameters post-operatively if required. Operative Parameters :Operation Type /Number of procedures/ Operative Blood Loss/ Peritoneal Contamination/ Malignancy Status/ CEPOD
  • 12. Calculate an O-POSSUM Score • Choose a value in each category that matches your patient from the drop down lists in both the physiological and operative parameters tables below. You must enter the patients actual age as well as selecting the age range otherwise an error will occur. Default values (the lowest score) are shown for each category. Simply submitting the form as it is without changing the values (i.e. a young fit patient having a minor operation) still gives a % risk for mortality.
  • 13. O Possum score • Physiological Parameters – Age Range – * BOTH FIELDS MUST BE COMPLETED – Actual Age * BOTH FIELDS MUST BE COMPLETED – Cardiac – Respiratory – ECG – Systolic BP – Pulse Rate – Haemoglobin – WBC – Urea – Sodium – Potassium – GCS – If calculating risk in a preoperative patient you will need to estimate the parameters below. You can return and modify the parameters post-operatively if required. • Operative Parameters :Operation Type/ Malignancy Status/ CEPOD
  • 14.
  • 15. Equazione di Possum(da Copeland) • R1 rischio di mortalità • R2:rischio di morbilità • Una volta ottenuti i punteggi: • - Ln (R1/1 - R1) = -7,04 + (0,13 x punteggio fisiologico) + (0,16 x punteggio di gravità operatoria). • - Ln (R2/1 - R2) = -5,91 + (0,16 x punteggio fisiologico) + (0,19 x punteggio di gravità operatoria).
  • 16. Equazioni di POSSUM • R1:Rischio di mortalità • R2:Rischio di morbilità: • Una volta ottenuti i punteggi: • R1=- Ln (R1/1 - R1) = -7,04 + (0,13 x punteggio fisiologico) + (0,16 x punteggio di gravità op). • R2=- Ln (R2/1 - R2) = -5,91 + (0,16 x punteggio fisiológico) + (0,19 x punteggio di gravità op)
  • 17. World J Surg Oncol. 2008 Apr 9;6:39. Application of Portsmouth modification of physiological and operative severity scoring system for enumeration of morbidity and mortality (P-POSSUM) in pancreatic surgery. Tamijmarane A, Bhati CS, Mirza DF, Bramhall SR, Mayer DA, Wigmore SJ, Buckels JA. • BACKGROUND: Pancreatoduodenectomy (PD) is associated with high incidence of morbidity and mortality. We have applied P-POSSUM in predicting the incidence of outcome after PD to identify those who are at the highest risk of developing complications. METHOD: A prospective database of 241 consecutive patients who had PD from January 2002 to September 2005 was retrospectively updated and analysed. P-POSSUM score was calculated for each patient and correlated with observed morbidity and mortality. RESULTS: 30 days mortality was 7.8% and morbidity was 44.8%. Mean physiological score was 16.07 +/- 3.30. Mean operative score was 13.67 +/- 3.42. Mean operative score rose to 20.28 +/- 2.52 for the complex major operation (p < 0.001) with 2 fold increase in morbidity and 3.5 fold increase in mortality. For groups of patients with a physiological score of (less than or equal to) 18, the O:P (observed to Predicted) morbidity ratio was 1.3-1.4 and, with a physiological score of >18, the O:P ratio was nearer to 1. Physiological score and white cell count were significant in a multivariate model. CONCLUSION: P-POSSUM underestimated the mortality rate. While P-POSSUM analysis gave a truer prediction of morbidity, underestimation of morbidity and potential for systematic inaccuracy in prediction of complications at lower risk levels is a significant issue for pancreatic surgery
  • 18. Stratification of morbidity according to physiology score Horizontal lines within boxes, boxes and error bars represent median, interquartile range and range respectively. P < 0.001 (Kruskal Wallis Test).
  • 19. Ding LA, Sun LQ, Chen SX, Qu LL, Xie DF. Modified physiological and operative score for the enumeration of mortality and morbidity risk assessment model in general surgery. World J Gastroenterol 2007; 13(38): 5090-5095 • AIM: To establish a scoring system for predicting the incidence of postoperative complications and mortality in general surgery based on the physiological and operative severity score for the enumeration of mortality and morbidity (POSSUM), and to evaluate its effi cacy. • METHODS: Eighty-four patients with postoperative complications or death and 172 patients without postoperative complications, who underwent surgery in our department during the previous 2 years, were retrospectively analyzed by logistic regression. Fifteen indexes were investigated including age, cardiovascular function, respiratory function, blood test results, endocrine function, central nervous system function, hepatic function, renal function, nutritional status, extent of operative trauma, and course of anesthesia. Modifi ed POSSUM (M-POSSUM) was developed using significant risk factors with its effi cacy evaluated. • RESULTS: The significant risk factors were found to be age, cardiovascular function, respiratory function, hepatic function, renal function, blood test results, endocrine function, nutritional status, duration of operation, intraoperative blood loss, and course of anesthesia. These factors were all included in the scoring system. There were signifi cant differences in the scores between the patients with and without postoperative complications, between the patients died and survived with complications, and between the patients died and survived without complications. The receiver operating characteristic curves showed that the M-POSSUM could accurately predict postoperative complications and mortality. • CONCLUSION: M-POSSUM correlates well with postoperative complications and mortality, and is more accurate than POSSUM
  • 20. physiological and operative severity score for the enumeration of mortality and morbidity (POSSUM) • POSSUM is limited by its somewhat subjective nature and incomplete evaluation of cardiac signs. We propose the modified POSSUM (M-POSSUM) as a reasonable, practical and objective scoring system that can be used across a broad disease spectrum in general surgery
  • 21.
  • 22. M-POSSUM indice 0 1 2 3 4 età <60 60-69 70-79 >80 Sist circolatorio Normale:funz.cardiaca,PA,ECG Funz cardiaca grado 1:lieve ipertens e anormalità ECG,bradicardia o tachic,sinoatriale,basso voltaggio derivaz arti inf,BBB Funz cardiaca grado 2:moderata ipertens controllata da terapia,extrasistoli atriale occasionali Funz.cardiaca grado 3:IM<3 mesi,ipertens moderata in terapia,ritmi ectopici,modificaz ST-T,fibrillaz.atriale. Insufficienza cardiaca seria,ins.cardiaca acuta,malattia ipertensiva Sist.respiratorio normale Fumo di vecchia data,bronchite cronica,asma,infezioni respiratorie,strie polmonari ,ispessimenti Modesta COPD,modesta alteraz.funz.resp,modesto enfisema Moderata COPD,funz resp da moderata a seriamente anormale Insufficienza respiratoria Funz.epatica normale Storia di epatite/cirrosi,bilirub tot.<34,2 mmol/l bilirub tot.34,2-51.3 mmol/l bilirub tot.>51.3 mmol/l Funz.renale normale BUN<10.1 mmol/lt,Creatinin.<170 mmol/l BUN 10.1-15 mmol/lt,creat 170-300 mmol/l Insuff renale in dialisi Tratto gastrointestinale normale Storia di gastroenterite cronica,ulcera peptica ben controllata Malattia gastrointest attiva/emorragia/perforaz di ulcera,m.di Crohn. attiva Fistola intest.percutanea Sindr.intestino corto,trapianto di intestino ematopoietico normale Piastrine /GB lievemente diminuiti,HB >85 gr/l Malattia,come leucemia ,stabile;GB>14.5 *109/l Mal.aplastica,sindr da ipersplenismo,leucemia,e cc. endocrino normale Glicemia lievemente aumentata,glucosio urinario assente,ipertiroidismo e ipotiroidsmo trattati,acromegalia,gotta,mal reumatoide Glicemia lievemente aumentata,glucosio urinario presente,diabete controll da terapia orale,ormonoterpia,gotta attiva Diabete instabile con terapia orale Nefropatia diabetica Stato nutrizionale normale Malnutrizione lieve;albumina 30-35 gr/l,decremento di peso <2.5 kg/m Malnutrizione moderata;albumina <30 gr/l,decremento di peso <2.5 -5 kg/m cachessia Glasgow Coma Score 15 12-14 9-11 = o <8 Ferita operatoria Minore/tempo operatorio < 2 h/emorragia<300 ml Moderata/tempo operatorio 2-4 h/emorragia300-500 ml Maggiore /tempo operatorio >4 h/emorragia>500 ml/escissionne di tumore Maggiore/escissione > 3 organi/malattia tumorale non resecabile l
  • 23. M Possum quadro 1 indice 0 1 2 3 4 età <60 60-69 70-79 >80 Sist circolatorio Normale:funz.c ardiaca,PA,ECG Funz cardiaca grado 1:lieve ipertens e anormalità ECG,bradicardia o tachic,sinoatrial e,basso voltaggio derivaz arti inf,BBB Funz cardiaca grado 2:moderata ipertens controllata da terapia,extrasis toli atriale occasionali Funz.cardiaca grado 3:IM<3 mesi,ipertens moderata in terapia,ritmi ectopici,modific az ST-T, fibrillaz.atrial e. Insufficienza cardiaca seria,ins.cardiac a acuta,malattia ipertensiva Sist.respiratorio normale Fumo di vecchia data,bronchite cronica,asma,in fezioni respiratorie,stri e polmonari ,ispessimenti Modesta COPD,modesta alteraz.funz.res p,modesto enfisema Moderata COPD,funz resp da moderata a seriamente anormale Insufficienza respiratoria
  • 24. M Possum quadro 2 0 1 2 3 4 Funz.epatica normale Storia di epatite/cirrosi, bilirub tot.<34,2 mmol/l bilirub tot.34,2-51.3 mmol/l bilirub tot.>51.3 mmol/l Funz.renale normale BUN<10.1 mmol/lt,Creati nin.<170 mmol/l BUN 10.1-15 mmol/lt,creat 170-300 mmol/l Insuff renale in dialisi Tratto gastrointesti nale normale Storia di gastroenterite cronica,ulcera peptica ben controllata Malattia gastrointest attiva/emorrag ia/perforaz di ulcera,m.di Crohn. attiva Fistola intest.percutan ea Sindr.intestino corto,trapianto di intestino
  • 25. M Possum quadro 3 0 1 2 3 4 ematopoiet ico normale Piastrine /GB lievemente diminuiti,HB >85 gr/l Malattia,co me leucemia ,stabile;GB>1 4.5 *109/l Mal.aplastica ,sindr da ipersplenism o,leucemia,e cc. endocrino normale Glicemia lievemente aumentata,gl ucosio urinario assente,ipert iroidismo e ipotiroidsmo trattati,acro megalia,gott a,mal reumatoide Glicemia lievemente aumentata,gl ucosio urinario presente,dia bete controll da terapia orale,ormon oterpia,gotta attiva Diabete instabile con terapia orale Nefropatia diabetica
  • 26. M Possum (quadro 4) 0 1 2 3 4 Stato nutrizionale normale Malnutrizione lieve;albumina 30- 35 gr/l,decremento di peso <2.5 kg/m Malnutrizione moderata;albumi na <30 gr/l,decremento di peso <2.5 -5 kg/m cachessia Glasgow Coma Score 15 12-14 9-11 = o <8 Ferita operatoria Minore/tempo operatorio < 2 h/emorragia<300 ml Moderata/tempo operatorio 2-4 h/emorragia300- 500 ml Maggiore /tempo operatorio >4 h/emorragia>500 ml/escissionne di tumore maligno Maggiore/escissio ne > 3 organi/malattia tumorale non resecabile l Decorso anestetico Aritmia/bassa PA < 30 min PA sempre bassa,rianimazion e cardiopolmonare
  • 27. Ding LA, Sun LQ, Chen SX, Qu LL, Xie DF. Modified physiological and operative score for the enumeration of mortality and morbidity risk assessment model in general surgery. World J Gastroenterol 2007; 13(38): 5090-5095
  • 28. Predictive formula of M POssum • Logistic regression analysis yielded statistically signifi cant equations for both morbidity and mortality. • The morbidity equation was : lnR/1-R = -7.287 + 0.765M-POSSUM (P =0.000) • the mortality equation was: lnR/1-R = -10.000 + 0.681M-POSSUM (P = 0.000). The predictive accuracy of morbidity equation and mortality equation was 83.6% and 94.1%, respectively
  • 29. O-POSSUM Score observed 30-day morbidity rate 58% Obs. Mortality 12% observed 1-year mortality 38% for males (mean age 79 years) and 29% for females (mean age 84 years). N Z Med J. 2006 May 19;119(1234):U1986. Comment in: N Z Med J. 2006;119(1234):U1981. Audit of morbidity and mortality following neck of femur fracture using the POSSUM scoring system. Young W, Seigne R, Bright S, Gardner M
  • 30. Malnutrition Universal Screening Tool (MUST) ‘MUST’ is a five-step screening tool to identify adults, who are malnourished, at risk of malnutrition, or obese. It also includes management guidelines which can be used to develop a care plan. The tool is being used both in hospitals and in the community. It is easy to use and can be used by all care workers. • Full details of this tool can be found at the following: • http://www.bapen.org.uk/the-must.htm • Calculate Risk • Use the form below to estimate the risk of malnutrition. Please note that the figures entered for weight must be in kilograms and the figure entered for height must be in centimetres. Conversion charts for Imperial units can be found here (opens in a new window). • Parameters Current weight (Kg) /Current height (cms) /Previous healthy weight* /Is the patient acutely ill and there has been or is likely to be no nutritional intake for >5 days? / • * This is the patients' weight when they were healthy, or the weight prior to any unplanned weight loss in the last 3-6 months
  • 31. Application of Portsmouth modification of physiological and operative severity scoring system for enumeration of morbidity and mortality (P-POSSUM) in pancreatic surgery Appou Tamijmarane*, Chandra S Bhati, Darius F Mirza, Simon R Bramhall, David A Mayer, Stephen J Wigmore and John AC Buckels.World Journal of Surgical Oncology • 2008, 6:39 doi:10.1186/1477-7819-6-39 Abstract Background: Pancreatoduodenectomy (PD) is associated with high incidence of morbidity and mortality. We have applied P-POSSUM in predicting the incidence of outcome after PD to identify those who are at the highest risk of developing complications. • Method: A prospective database of 241 consecutive patients who had PD from January 2002 to September 2005 was retrospectively updated and analysed. P-POSSUM score was calculated for each patient and correlated with observed morbidity and mortality. • Results: 30 days mortality was 7.8% and morbidity was 44.8%. Mean physiological score was 16.07 ± 3.30. Mean operative score was 13.67 ± 3.42. Mean operative score rose to 20.28 ± 2.52 for the complex major operation (p < 0.001) with 2 fold increase in morbidity and 3.5 fold increase in mortality. For groups of patients with a physiological score of (less than or equal to) 18, the O:P • (observed to Predicted) morbidity ratio was 1.3–1.4 and, with a physiological score of >18, the O:P ratio was nearer to 1. Physiological score and white cell count were significant in a multivariate model. • Conclusion: P-POSSUM underestimated the mortality rate. While P-POSSUM analysis gave a truer prediction of morbidity, underestimation of morbidity and potential for systematic inaccuracy in prediction of complications at lower risk levels is a significant issue for pancreatic surgery.
  • 32. E-PASS scoring Estimation of physiologic ability and surgical stress
  • 33. • Estimation of Physiologic Ability and Surgical Stress (E-PASS) scoring system: • E-PASS=a pre-operative risk score (PRS), a surgical stress score (SSS), and a comprehensive risk score (CRS), which is calculated from the PRS and SSS. • CRS=PRS+SSS • E-PASS=K*CRS
  • 34. equations of the E-PASS scoring system • The equations of the E-PASS scoring system are as follows (data from Haga et al1): (1) Estimation of physiologic ability and surgical stress (E-PASS) as a predictor of immediate outcome after elective abdominal aortic aneurysm surgery
  • 35. equations of the E-PASS scoring system are as follows (data from Haga et al1): • (1) PRS = -0.0686 + 0.00345X1 +0.323X2 +0.205X3 +0.153X4 +0.148X5 +0.0666X6, where X1 is age; X2, the presence (1) or absence (0) of severe heart disease; X3, the presence (1) or absence (0) of severe pulmonary disease; X4, the presence (1) or absence (0) of diabetes mellitus; X5, the performance status index (range, 0-4); and X6, the American Society of Anesthesiologists' physiological status classification (range, 1-5).
  • 36. • (1) PRS = -0.0686 + 0.00345X1 +0.323X2 +0.205X3 +0.153X4 +0.148X5 +0.0666X6, dove: X1 è etò, X2,la presenza (1) o assenza (0) di malattia cardiaca severa; X3 la presenza (1) o assenza (0)di malattia polmonare severa; X4, la presenza (1) o assenza (0) di diabete mellitus; X5, il performance status index (range, 0-4); X6, la classificazione di stato fisico della American Society of Anesthesiologists (ASA Ps) (range, 1- 5).
  • 37. • Severe heart disease is defined as heart failure of New York Heart Association class III or IV or severe arrhythmia requiring mechanical support. • Severe pulmonary disease is defined as any condition with a percentage vital capacity of less than 60% and/or a percentage forced expiratory volume in 1 second of less than 50%. • Diabetes mellitus is defined according to the World Health Organization criteria. • Performance status index is defined by the Japanese Society for Cancer Therapy.
  • 38. SSS:surgical stress core • (2) SSS = -0.342 + 0.0139X1 +0.0392X2 +0.352X3, where X1 is blood loss (in grams) divided by body weight (in kilograms); X2, the operating time (in hours); and X3, the extent of the skin incision (0 indicates a minor incision for laparoscopic or thoracoscopic surgery, including laparoscopic- or thoracoscopic-assisted surgery; 1, laparotomy or thoracotomy alone; and 2, laparotomy and thoracotomy). (
  • 39. • 2) SSS = -0.342 + 0.0139X1 +0.0392X2 +0.352X3, dove X1 è la perdita ematica (in grammi) diviso per il peso corporeo (in kg); X2, tempo operatorio ( h); X3, l’estensione della incisione cutanea: (0 indica una incisione minore laparoscopica o toracoscopica; 1, laparotomia o toracototomia da sole ; 2, laparotomia e toracotomia
  • 40. comprehensive risk score (CRS) • 3) CRS = -0.328 + (0.936 x PRS) + (0.976 x SSS).
  • 41. Esempio di di EPass • 70 anni • Copd • Iperteso • Gastrect 5 h,perdite 800 ml stimate……. • PRS = -0.0686 + 0.00345*70+0.323*0 +0.205*1 +0.153X4 +0.148*??X5 +0.0666*3,assumiamo X5=1… • PRS=3,49 • SSS =0,4345 • CRS = -0.328 + (3,26) + (0,4240).=3,35 ,cioè mortalità 0-5%,morbilità 44%
  • 42. Incidence of mortality and morbidity accordingto CRS. The graph appears to demonstrate that patients in the ≥1.0 categoryare at particularly high risk of mortality, and in the .5 to <1.0 and ≥1.0categories at particularly high risk of morbidity. Bars show 95% confidence intervals Estimation of physiologic ability and surgical stress (E-PASS) as a predictor of immediate outcome after elective abdominal aortic aneurysm surgery
  • 43. Estimation of physiologic ability and surgical stress (E-PASS) as a predictor of immediate outcome after elective abdominal aortic aneurysm surgery
  • 44. Br J Surg. 2007 Jun;94(6):717-21. Comment in: Br J Surg. 2007 Oct;94(10):1308; author reply 1308-9. VBHOM, a data economic model for predicting the outcome after open abdominal aortic aneurysm surgery. Tang T, Walsh SR, Prytherch DR, Lees T, Varty K, Boyle JR; Audit Research Committee of the Vascular Society of Great Britain and Ireland. • BACKGROUND: Vascular Biochemistry and Haematology Outcome Models (VBHOM) adopted the approach of using a minimum data set to model outcome. This study aimed to test such a model on a cohort of patients undergoing open elective and non-elective abdominal aortic aneurysm (AAA) repair. METHODS: A binary logistic regression model of risk of in-hospital mortality was built from the 2002-2004 submission to the UK National Vascular Database (NVD) (2718 patients). The subset of NVD data items used comprised serum levels of urea, sodium and potassium, haemoglobin, white cell count, sex, age and mode of admission. The model was applied prospectively using Hosmer-Lemeshow methodology to a test data set from the Cambridge Vascular Unit. RESULTS: The validation set contained 327 patients, of whom 208 had elective AAA repair and 119 had emergency repair of a ruptured AAA. Outcome following elective and non-elective AAA repair could be described accurately using the same model. The overall mean predicted risk of death was 14.13 per cent, and 48 deaths were predicted. The actual number of deaths was 53 (chi(2) = 8.40, 10 d.f., P = 0.590; no evidence of lack of fit). The model also demonstrated good discrimination (c-index = 0.852). CONCLUSION: The VBHOM approach has the advantage of using simple, objective clinical data that are easy to collect routinely. The VBHOM data items potentially allow prediction of risk in an individual patient before aneurysm surgery. (c) 2007 British Journal of
  • 45. Vascular Biochemistry and Haematology Outcome Models (VBHOM) • serum levels of: – urea, –sodium and potassium, –haemoglobin, –white cell count, –sex, –age – mode of admission.
  • 46. Eur J Vasc Endovasc Surg. 2007 Nov;34(5):505-13. Epub 2007 Sep 14. Links Comment in: Eur J Vasc Endovasc Surg. 2007 Nov;34(5):497-8. Comparison of risk-scoring methods in predicting the immediate outcome after elective open abdominal aortic aneurysm surgery. Tang TY, Walsh SR, Fanshawe TR, Seppi V, Sadat U, Hayes PD, Varty K, Gaunt ME, Boyle JR. • BACKGROUND & OBJECTIVES: The aim of this study was to apply three simple risk - scoring systems to prospectively collected data on all elective open Abdominal Aortic Aneurysm (AAA) operations in the Cambridge Academic Vascular Unit over a 6 - year period (January 1998 to January 2004), to compare their predictive values and to evaluate their validity with respect to prediction of mortality and post-operative complications. METHODS: 204 patients underwent elective open infra-renal AAA repair. Data were prospectively collected and risk assessment scores were calculated for mortality and morbidity according to the Glasgow Aneurysm Score (GAS), VBHOM (Vascular Biochemistry and Haematology Outcome Models) and Estimation of Physiologic Ability and Surgical Stress (E-PASS). RESULTS: The mortality rate was 6.3% (13/204) and 59% (121/204) experienced a post-operative complication (30-day outcome). For GAS, VBHOM and E-PASS the receiver operating characteristics (ROC) curve analysis for prediction of in-hospital mortality showed area under the curve (AUC) of 0.84 (95% confidence interval [CI], 0.76 to 0.92; p<0.0001), 0.82 (95% CI, 0.68 to 0.95; p=0.0001) and 0.92 (95% CI, 0.87 to 0.97; p<0.0001) respectively. There were also significant correlations between post-operative complications and length of hospital stay and each of the three scores, but the correlation was substantially higher in the case of E-PASS. CONCLUSIONS: All three scoring systems accurately predicted the risk of mortality and morbidity in patients undergoing elective open AAA repair. Among these, E-PASS seemed to be the most accurate predictor in this patient population.
  • 47. Eur J Vasc Endovasc Surg. 2008 Oct 13. [Epub ahead of print] Links Predicting Risk in Elective Abdominal Aortic Aneurysm Repair: A Systematic Review of Current Evidence. Patterson BO, Holt PJ, Hinchliffe R, Loftus IM, Thompson MM • . OBJECTIVE: To examine and compare existing pre-operative risk prediction methods for elective abdominal aortic aneurysm (AAA) repair. DESIGN: Systematic review. METHODS: Medline, EMBASE and the Cochrane library were searched for articles that related to risk prediction models used for elective AAA repair. RESULTS: 680 abstracts were reviewed and after exclusions 28 articles encompassing 10 risk models were identified. The most frequently studied of these were the Glasgow Aneurysm Score (GAS), the Physiological and Operative Severity Score for enUmeration of Mortality (POSSUM) predictor equation and the Vascular Biochemistry and Haematology Outcome Model (VBHOM). All models had strengths and weaknesses and some had unique features which were identified and discussed. CONCLUSION: The GAS appeared to be the most useful and consistently validated score at present for open repair. Other systems were either not validated fully or were not consistently accurate. Some had significant drawbacks which appeared to severely limit their clinical application. Recent work has shown that no scores consistently predicted the risk associated with endovascular aneurysm repair (EVAR). Pre-operative risk stratification is a vital component of modern surgical practice, and we propose the need for a comprehensive new risk scoring method for AAA repair incorporating anatomical and physiological data.
  • 49. Surgical Apgar Score Regenbogen, Scott E. MD, MPH *+; Lancaster, R Todd MD *+; Lipsitz, Stuart R. ScD ++; Greenberg, Caprice C. MD, MPH ++; Hutter, Matthew M. MD, MPH +; Gawande, Atul A. MD, MPH *++ Does the Surgical Apgar Score Measure Intraoperative Performance? Annals of Surgery. 248(2):320-328, August 2008. • lowest heart rate • lowest mean arterial pressure • estimated blood loss • A score built from these 3 predictors has proved strongly predictive of the risk of major postoperative complications and death in general and vascular surgery. • The score was thus developed using these 3 variables, and their beta coefficients were used to weight the points allocated to each variable in a 10-point score (Table 1).
  • 50. Regenbogen, Scott E. MD, MPH *+; Lancaster, R Todd MD *+; Lipsitz, Stuart R. ScD ++; Greenberg, Caprice C. MD, MPH ++; Hutter, Matthew M. MD, MPH +; Gawande, Atul A. MD, MPH *++ Does the Surgical Apgar Score Measure Intraoperative Performance? Annals of Surgery. 248(2):320-328, August 2008.
  • 51.
  • 52. Regenbogen, Scott E. MD, MPH *+; Lancaster, R Todd MD *+; Lipsitz, Stuart R. ScD ++; Greenberg, Caprice C. MD, MPH ++; Hutter, Matthew M. MD, MPH +; Gawande, Atul A. MD, MPH *++ Does the Surgical Apgar Score Measure Intraoperative Performance? Annals of Surgery. 248(2):320-328, August 2008.
  • 53. Regenbogen, Scott E. MD, MPH *+; Lancaster, R Todd MD *+; Lipsitz, Stuart R. ScD ++; Greenberg, Caprice C. MD, MPH ++; Hutter, Matthew M. MD, MPH +; Gawande, Atul A. MD, MPH *++ Does the Surgical Apgar Score Measure Intraoperative Performance? Annals of Surgery. 248(2):320-328, August 2008.
  • 54. Regenbogen, Scott E. MD, MPH *+; Lancaster, R Todd MD *+; Lipsitz, Stuart R. ScD ++; Greenberg, Caprice C. MD, MPH ++; Hutter, Matthew M. MD, MPH +; Gawande, Atul A. MD, MPH *++ Does the Surgical Apgar Score Measure Intraoperative Performance? Annals of Surgery. 248(2):320-328, August 2008.
  • 55. Frequenza delle complicanze a seconda del Surgical Apgar Score Regenbogen, Scott E. MD, MPH *+; Lancaster, R Todd MD *+; Lipsitz, Stuart R. ScD ++; Greenberg, Caprice C. MD, MPH ++; Hutter, Matthew M. MD, MPH +; Gawande, Atul A. MD, MPH *++ Does the Surgical Apgar Score Measure Intraoperative Performance? Annals of Surgery. 248(2):320-328, August 2008. 80 70 60 50 40 30 20 10 0 Ko maggiori 0-2 3-4 5-6 7-8 9-10 %
  • 56. Apache III • the APACHE III is used to produce an equation predicting hospital mortality after the first day of ICU treatment. There are 4 components: age, major disease category (reason for ICU admission), acute (current) physiology, and prior site of healthcare (eg, hospital floor, emergency room, etc.). The physiologic variables require scoring of the following vital sign and laboratory abnormalities: pulse rate, mean blood pressure, temperature, respiratory rate, PaO2/P (A-a) O2, hematocrit, white blood cell count, creatinine, urine output, blood urea nitrogen, serum sodium, albumin, bilirubin, glucose, acid-base status, and neurologic status. • The last 2 physiologic parameters are hybrid values specific to APACHE III.[3] It is important to note that an additional scoring variable must be used to update the APACHE III score based on changes in the patient's physiologic status.
  • 57. references • Knaus WA, Draper EA, Wagner DP it al. APACHE II: A severity of disease classification system. Crit Care Med. 1985;13:818-829. • Le Gall Jr, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957-2963. • Knaus WA, Wagner DP, Draper EA et al. The APACHE III Prognostic System. Chest. 1991;100:1619-1636. • Beck DH, Taylor BL, Millar B, et al. Prediction of outcome from intensive care: A prospective cohort study comparing Acute Physiology and Chronic Health Evaluation II and III prognostic systems in a United Kingdom intensive care unit. Crit Care Med. 1997;25:9-15.
  • 58.
  • 59.
  • 60.
  • 64. Comparison of the performance of SAPS II, SAPS 3, APACHE II, and their customized prognostic models in a surgical intensive care unit Y. Sakr1, C. Krauss1, A. C. K. B. Amaral2, A. Réa-Neto2, M. Specht1, K. Reinhart1 and G. Marx1 • We compared the performance of SAPS 3 with SAPS II and the Acute Physiology and Chronic Health Evaluation (APACHE) II score in surgical ICU patients. • Methods: Prospectively collected data from all patients admitted to a German university hospital postoperative ICU between August 2004 and December 2005 were analysed. The probability of ICU mortality was calculated for SAPS II, APACHE II, adjusted APACHE II (adj- APACHE II), SAPS 3, and SAPS 3 customized for Europe [C-SAPS3 (Eu)] using standard formulas. To improve calibration of the prognostic models, a first-level customization was performed, using logistic regression on the original scores, and the corresponding probability of ICU death was calculated for the customized scores (C-SAPS II, C-SAPS 3, and C-APACHE II). • Results: The study included 1851 patients. Hospital mortality was 9%. Hosmer and Lemeshow statistics showed poor calibration for SAPS II, APACHE II, adj-APACHE II, SAPS 3, and C-SAPS 3 (Eu), but good calibration for C-SAPS II, C-APACHE II, and C-SAPS 3. Discrimination was generally good for all models [area under the receiver operating characteristic curve ranged from 0.78 (C-APACHE II) to 0.89 (C-SAPS 3)]. The C-SAPS 3 score appeared to have the best calibration curve on visual inspection. • Conclusions: In this group of surgical ICU patients, the performance of SAPS 3 was similar to that of APACHE II and SAPS II. Customization improved the calibration of all prognostic models.
  • 65. Comparison of Apache II,Saps and Sofa scores